FDA Drug Application (020896) for XELODA by HOFFMANN LA ROCHE

Back to FDA Applications sponsored by HOFFMANN LA ROCHE

Application Number020896
Product Number001
FormTABLET;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameXELODA
Active IngredientCAPECITABINE

Active IngredientCount
List of drugs with Active Ingredient CAPECITABINE2


Back to FDA Applications sponsored by HOFFMANN LA ROCHE